Pfizer Inc.
Therapeutic nanoparticles comprising a protonatable nitrogen therapeutic agent and methods of making and using same

Last updated:

Abstract:

The present disclosure generally relates to nanoparticles comprising a substantially hydrophobic acid, a basic therapeutic agent having a protonatable nitrogen, and a polymer. Other aspects include methods of making and using such nanoparticles.

Status:
Grant
Type:

Utility

Filling date:

7 Sep 2018

Issue date:

10 Mar 2020